Cambodia Pharmaceuticals & Healthcare Q1 2019
Cambodia’s ongoing epidemiological transition will continue to drive the rising burden of chronic diseases, boostingrevenue-earning opportunities for drugmakers. However, the country's underdeveloped healthcare infrastructure will continue tolimit access to treatment in the near term. We expect the gradual rolling out of universal access to healthcare to take time tomaterialise, which will face additional headwinds due to economic deceleration in the near term. Over the long term, the Chinese-lead Belt And Road initiative will benefit Cambodia’s economic development while supporting health sector growth.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook